Navigation Links
Provectus Pharmaceuticals, Inc.'s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Date:5/7/2012

NEW YORK, May 7, 2012 /PRNewswire/ -- Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, today announced that its May 3rd RetailInvestorConferences.com presentation is now available for on-demand viewing.

LINK: www.retailinvestorconferences.com > red "register/ watch event now" button

Provectus Pharmaceuticals, Inc's presentation will be available for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks.

About Provectus Pharmaceuticals Inc.

Provectus Pharmaceuticals (PVCT) specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and cancers of the liver. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. Its dermatological drug PH-10 also targets abnormal or diseased cells, with the current focus on psoriasis and atopic dermatitis. Provectus has recently completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis.

About RetailInvestorConferences.com

Since 2010, RetailInvestorConferences.com, created by BetterInvesting (NAIC) PR Newswire and MUNCmedia, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a
'/>"/>

SOURCE Provectus Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Solta Medical Receives Provectus Innovation Award at MDB Capital Groups Bright Lights Intellectual Property Conference
2. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
3. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
4. Avion Pharmaceuticals, LLC Names Michael Sullivan as new VP, Sales and Marketing
5. Auxilium Pharmaceuticals, Inc. and FCB I LLC Receive Paragraph IV Certification Notice from Watson Laboratories, Inc. for Testim®
6. Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™
7. Optimer Pharmaceuticals, Inc. Announces Presentation at ECCMID of Post-Hoc Subgroup Analysis of DIFICID in Adult Cancer Patients Being Treated for Clostridium difficile-Associated Diarrhea (CDAD)
8. Gamma Pharmaceuticals, Inc. Announces Key Appointment in Sales and Marketing
9. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results
10. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year-End 2011 Financial Results
11. Tibet Pharmaceuticals, Inc. Announces Intent to Go Private
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... and CAMBRIDGE, Mass., May 28, 2015 /PRNewswire/ ... investigating whether certain officers and directors ... duties to shareholders.  Eleven Biotherapeutics is a clinical-stage ... development of protein therapeutics to treat eye diseases, ... .   View this press release ...
(Date:5/28/2015)... 28, 2015 National Community Pharmacists Association (NCPA) ... the following statement in response to a new ... documenting that a number of generic drug costs increased ... with concerns previously expressed by NCPA and underscores the ... to essential medications. Moreover, a 2015 survey of 700 ...
(Date:5/28/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/324sfl/global_biomedical ) ... Biomedical Metal Market 2015-2019" report to their ... to grow at a CAGR of 7.27% over ... used for a number of applications in the ... steel, titanium-based alloys, cobalt-based alloys, nitinol, magnesium and ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of Eleven Biotherapeutics, Inc. (EBIO) on Behalf of Shareholders 2NCPA: AARP Drug Pricing Report Reiterates Need for Fair Generic Drug Reimbursements 2Global Biomedical Metal Market 2015-2019 with Biomet, Dentsply, Invibio & Wright Medical Group Dominating 2
... ATLANTA, July 18, 2011 Among the many new features ... with a simple way to deliver highly conformal stereotactic plans ... a target as the treatment beam rotates around the patient. ... Food and Drug Administration. "DCA can be used ...
... Caliper Life Sciences, Inc. (NASDAQ: CALP ... life science companies, today announced that Kevin Hrusovsky, President ... Stock Market Opening Bell on Tuesday, July 19th and ... customers to participate in this special event. This event ...
Cached Medicine Technology:New Release of Elekta's Monaco Treatment Planning System Prepares Software for Stereotactic Radiation Therapy 2Caliper Life Sciences to Ring The NASDAQ Stock Market Opening Bell on Tuesday, July 19 2Caliper Life Sciences to Ring The NASDAQ Stock Market Opening Bell on Tuesday, July 19 3
(Date:5/28/2015)... May 28, 2015 Three years ago, Dr. ... for his Shore Vascular & Vein Center! Dr. ... system. It is his mission to provide the highest ... , Dr. Jeffrey Gosin is Board Certified in ... University of Pennsylvania and Jefferson Medical College. He completed a ...
(Date:5/28/2015)... 2015 Are policies that spell out ... stay triggering financial pain for seniors? That’s what a ... Managed Care set to figure out, and its findings ... change. , The study, “Observation Encounters and Subsequent Nursing ... MPH, examined how Medicare policies that distinguish between an ...
(Date:5/28/2015)... The Paw Project, an international nonprofit ... to educate the Oregon public about the harmful consequences ... Market Street and Park Avenue in Salem, Oregon's state ... Cats, Raise Your Hand,” depicts a human hand with ... graphic and anatomically-correct representation of the declaw surgery performed ...
(Date:5/28/2015)... May 28, 2015 " Trends Investing ” ... Report, which takes a look at small, medium, and large ... host of NewsWatch and business expert, conducted the business review ... users to where they should invest their money. , The ... concept. But doing it and knowing how to succeed ...
(Date:5/28/2015)... FL (PRWEB) May 28, 2015 Nidra Herbal ... incredibly gentle on the body. A non-addictive supplement, Nidra Herbal ... blend of natural ingredients will leave users with a real ... system of care , Ayurveda, which translates as the “Science ... than 5,000 years ago and is a holistic system of ...
Breaking Medicine News(10 mins):Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 3Health News:Declawing is Cruel, Education is the Key - Says the Paw Project 2Health News:Declawing is Cruel, Education is the Key - Says the Paw Project 3Health News:An Application to Learn Where to Invest Money was Featured on NewsWatch Television 2Health News:Ayurveda Herba Corp’s Revolutionary Herbal Sleep Supplement is Now Available from Amazon.com 2
... It might be a good idea to use heart bypass ... of leaky mitral valves, a new study shows. Surgeons ... operations. The study findings suggest, however, that the procedure to ... of the heart and can become leaky if their flaps ...
... at the Toronto Western Research Institute (TWRI), Krembil Neuroscience ... against the damaging effects of a stroke in a ... a few years. At this point, it has reached ... to reduce the brain,s vulnerability to stroke damage (termed ...
... (HealthDay News) -- Federal laws requiring medical companies to conduct ... safe or effective for children to use certain medications, a ... (IOM) report noted, however, that there,s still not enough data ... effects of drugs on kids generally. The IOM, part of ...
... Garcia will deliver the keynote address, "The Harris County Jail: ... Friday (March 2) at the University of Houston (UH), Rockwell ... keynote address. A question-and-answer period will follow. The ... Social Work Awards Breakfast hosted by the UH Graduate College ...
... NEW YORK, February 29, 2012 A new method ... at Polytechnic Institute of New York University (NYU-Poly), promises ... of cancers, heart disorders and Alzheimer,s disease, as well ... and cartilage. , In addition, applied differently, this same ...
... release is available in French . ... CHUM Hospital,s International Health, will be joining the World Health ... funding of the fight against Noma. This disease, scientifically called ... Sub-Saharan Africa. Despite the existence of a cheap and easy ...
Cached Medicine News:Health News:Combining Heart Valve Repair With Bypass May Be Worthwhile 2Health News:Canadian scientist develops world's most advanced drug to protect the brain after a stroke 2Health News:Efforts to Improve Research on Kids' Drugs Paying Off: Report 2Health News:Sheriff Adrian Garcia delivers keynote at social work awards breakfast 2Health News:Nanofiber breakthrough holds promise for medicine and microprocessors 2Health News:Montrealer heads to Congo to fight childhood disfigurement 2
Apron,special Proceddure...
Use this workhorse apron where 360 of protection from direct and scatter radiation is required....
Hip-hugging design transfers weight from shoulders to the hips. Crisscross shoulder design provides snug and comfortable upper torso fit while preventing apron from slipping off shoulders....
Mini Aprons are half aprons with an easy-on, easy-off Velcro-style closure that fastens securely in seconds. Color-coded sizes for easy identification. Offers 0.5 mm Pb equivalent protection....
Medicine Products: